Carfilzumib vs Bortezamib

Dilip: Carfilzumib seems to be the most potent of all proteosome inhibitors. It's an irreversible proteosome inhibitor and it seems to be most efficacious. Do you need to give anything at the back end of the transplant is debatable I think. Dilip wants you to cite data showing car filsumib is superior to Bortezamib. But remember this was a transplant deferred patient population. That's not where we're using carFilzumib.